These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7087093)

  • 1. Malignant glioma. Results of combined modality therapy.
    Cooper JS; Borok TL; Ransohoff J; Carella RJ
    JAMA; 1982 Jul; 248(1):62-5. PubMed ID: 7087093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon as adjuvant therapy with initial radiotherapy of patients with anaplastic gliomas.
    Mahaley MS; Urso MB; Whaley RA; Williams TE; Guaspari A
    J Neurosurg; 1984 Dec; 61(6):1069-71. PubMed ID: 6209367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pattern of care of high-grade gliomas].
    Laigle-Donadey F; Sanson M
    Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy in malignant gliomas].
    Heuser K
    Neurochirurgia (Stuttg); 1990 Oct; 33 Suppl 1():20-2. PubMed ID: 2293042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of high-grade gliomas in the elderly.
    Brandes A; Fiorentino MV
    Oncology; 1998; 55(1):1-6. PubMed ID: 9428367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boost irradiation in postoperative treatment of malignant gliomas--survival results.
    Pirtoli L; Sebaste L; Tucci E; Pepi F; Bindi M; Bellezza A
    Rays; 1988; 13(3):117-22. PubMed ID: 3256007
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center.
    Chin HW; Young AB; Maruyama Y
    Cancer Treat Rep; 1981; 65(1-2):45-51. PubMed ID: 7013978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of malignant glioma. Apropos of 39 cases].
    Louarn F; Brun B; Lebourgeois JP; Djindjian M; Claude C; Barbizet J
    Sem Hop; 1983 Feb; 59(7):438-43. PubMed ID: 6302881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative carmustine chemotherapy for malignant brain tumors.
    Butti G; Knerich R; Tanghetti B; Adinolfi D; Gaetani P; Buoncristiani P; Paoletti P
    Cancer Treat Rep; 1984 Dec; 68(12):1505-6. PubMed ID: 6391664
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas.
    Yung WK; Janus TJ; Maor M; Feun LG
    J Neurooncol; 1992 Feb; 12(2):131-5. PubMed ID: 1560258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of conventional radiotherapy in malignant gliomas:].
    Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M
    Gan No Rinsho; 1989 Sep; 35(11):1240-6. PubMed ID: 2554004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
    Würschmidt F; Bünemann H; Heilmann HP
    Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern approach to WHO grade II glioma classification and treatment--review of the literature].
    Recławowicz D; Stempniewicz M; Biernat W; Słoniewski P
    Neurol Neurochir Pol; 2008; 42(6):536-45. PubMed ID: 19235107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
    Levin VA; Wilson CB; Davis R; Wara WM; Pischer TL; Irwin L
    J Neurosurg; 1979 Oct; 51(4):526-32. PubMed ID: 225456
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques.
    Rubino G; Sacco P; Cerase A; Volterrani L; Sebaste L; Pepi F; Pirtoli L
    Radiol Med; 2004; 107(1-2):128-35. PubMed ID: 15031704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malignant gliomas in the elderly.
    Pierga JY; Hoang-Xuan K; Feuvret L; Simon JM; Cornu P; Baillet F; Mazeron JJ; Delattre JY
    J Neurooncol; 1999 Jun; 43(2):187-93. PubMed ID: 10533732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of combined modality treatment of malignant gliomas. Comparison of postoperative irradiation, chemotherapy, and combined radio-polychemotherapy (author's transl)].
    Jellinger K; Volc D; Podreka I; Grisold W; Flament H; Vollmer R; Weiss R
    Nervenarzt; 1981 Jan; 52(1):41-50. PubMed ID: 7219613
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized phase III trial of single versus multiple chemotherapeutic treatment following surgery and during radiotherapy for patients with anaplastic gliomas.
    Mahaley MS; Whaley RA; Krigman MR; Bouldin TW; Bertsch L; Cush S
    Surg Neurol; 1987 May; 27(5):430-2. PubMed ID: 3551160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.
    Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G
    Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.